EMAIL THIS PAGE TO A FRIEND

PloS one

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.


PMID 26252954

Abstract

The cystine-glutamate antiporter (system xc-) is a Na+-independent amino acid transporter that exchanges extracellular cystine for intracellular glutamate. It is thought to play a critical role in cellular redox processes through regulation of intracellular glutathione synthesis via cystine uptake. In gliomas, system xc- expression is universally up-regulated while that of glutamate transporters down-regulated, leading to a progressive accumulation of extracellular glutamate and excitotoxic cell death of the surrounding non-tumorous tissue. Additionally, up-regulation of system xc- in activated microglia has been implicated in the pathogenesis of several neurodegenerative disorders mediated by excess glutamate. Consequently, system xc- is a new drug target for brain cancer and neuroinflammatory diseases associated with excess extracellular glutamate. Unfortunately no potent and selective small molecule system xc- inhibitors exist and to our knowledge, no high throughput screening (HTS) assay has been developed to identify new scaffolds for inhibitor design. To develop such an assay, various neuronal and non-neuronal human cells were evaluated as sources of system xc-. Human glioma cells were chosen based on their high system xc- activity. Using these cells, [14C]-cystine uptake and cystine-induced glutamate release assays were characterized and optimized with respect to cystine and protein concentrations and time of incubation. A pilot screen of the LOPAC/NINDS libraries using glutamate release demonstrated that the logistics of the assay were in place but unfortunately, did not yield meaningful pharmacophores. A larger, HTS campaign using the 384-well cystine-induced glutamate release as primary assay and the 96-well 14C-cystine uptake as confirmatory assay is currently underway. Unexpectedly, we observed that the rate of cystine uptake was significantly faster than the rate of glutamate release in human glioma cells. This was in contrast to the same rates of cystine uptake and glutamate release previously reported in normal human fibroblast cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

294993
Ammonia, anhydrous, ≥99.98%
H3N
779423
Ammonia solution, 4 M in methanol
H3N
718939
Ammonia solution, 0.4 M in THF
H3N
608777
Ammonia-14N, 99.99 atom % 14N
H314N
C7527
Choline chloride, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
C5H14ClNO
C7017
Choline chloride, ≥99%
C5H14ClNO
C1879
Choline chloride, ≥98%
C5H14ClNO
26978
Choline chloride, BioUltra, ≥99.0% (AT)
C5H14ClNO
C8630
DL-Cystine
C6H12N2O4S2
E3024 Earle’s Balanced Salts, With sodium bicarbonate, without phenol red, liquid, sterile-filtered, suitable for cell culture
G7882 L-Glutamic Dehydrogenase from bovine liver, Type III, lyophilized powder, ≥20 units/mg protein
M2643
Magnesium sulfate, BioReagent, suitable for cell culture, suitable for insect cell culture
MgSO4
203726
Magnesium sulfate, ≥99.99% trace metals basis
MgSO4
M3409
Magnesium sulfate solution, for molecular biology, 1.00 M±0.04 M
MgSO4
83266
Magnesium sulfate solution, BioUltra, for molecular biology
MgSO4
P5655
Potassium phosphate monobasic, powder, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
H2KO4P
RES20760-A7
Potassium phosphate monobasic, PharmaGrade, NF, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
H2KO4P
P8416
Potassium phosphate monobasic, plant cell culture tested, ≥99%
H2KO4P
P9791
Potassium phosphate monobasic, for molecular biology, ≥98.0%
H2KO4P
229806
Potassium phosphate monobasic, 99.99% trace metals basis
H2KO4P
P5379
Potassium phosphate monobasic, ReagentPlus®
H2KO4P
60218
Potassium phosphate monobasic, BioUltra, for molecular biology, anhydrous, ≥99.5% (T)
H2KO4P